146 related articles for article (PubMed ID: 30441940)
1. Celiac disease in children and adolescents.
Frühauf P; Nabil El-Lababidi N; Szitányi P
Cas Lek Cesk; 2018; 157(3):117-121. PubMed ID: 30441940
[TBL] [Abstract][Full Text] [Related]
2. Celiac disease without villous atrophy in children: a prospective study.
Kurppa K; Ashorn M; Iltanen S; Koskinen LL; Saavalainen P; Koskinen O; Mäki M; Kaukinen K
J Pediatr; 2010 Sep; 157(3):373-80, 380.e1. PubMed ID: 20400102
[TBL] [Abstract][Full Text] [Related]
3. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
[TBL] [Abstract][Full Text] [Related]
4. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
7. Future treatment strategies for celiac disease.
Lindfors K; Lähdeaho ML; Kalliokoski S; Kurppa K; Collin P; Mäki M; Kaukinen K
Expert Opin Ther Targets; 2012 Jul; 16(7):665-75. PubMed ID: 22620264
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
9. Small bowel villous atrophy: celiac disease and beyond.
Elli L; Branchi F; Sidhu R; Guandalini S; Assiri A; Rinawi F; Shamir R; Das P; Makharia GK
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):125-138. PubMed ID: 28000520
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease.
Rossi T
Adolesc Med Clin; 2004 Feb; 15(1):91-103, ix. PubMed ID: 15272258
[TBL] [Abstract][Full Text] [Related]
11. [Celiac disease--the chameleon among the food intolerances].
Ströhle A; Wolters M; Hahn A
Med Monatsschr Pharm; 2013 Oct; 36(10):369-80; quiz 381-2. PubMed ID: 24266248
[TBL] [Abstract][Full Text] [Related]
12. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
13. [Refractory celiac disease].
Iwańczak F; Iwańczak B
Pol Merkur Lekarski; 2013 Jul; 35(205):47-50. PubMed ID: 23984606
[TBL] [Abstract][Full Text] [Related]
14. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists.
Collin P; Reunala T
Am J Clin Dermatol; 2003; 4(1):13-20. PubMed ID: 12477369
[TBL] [Abstract][Full Text] [Related]
15. Gluten-free diet and quality of life in patients with screen-detected celiac disease.
Mustalahti K; Lohiniemi S; Collin P; Vuolteenaho N; Laippala P; Mäki M
Eff Clin Pract; 2002; 5(3):105-13. PubMed ID: 12088289
[TBL] [Abstract][Full Text] [Related]
16. Coeliac disease--a diagnostic and therapeutic challenge.
Kaukinen K; Lindfors K; Collin P; Koskinen O; Mäki M
Clin Chem Lab Med; 2010 Sep; 48(9):1205-16. PubMed ID: 20578966
[TBL] [Abstract][Full Text] [Related]
17. Review and practice guidelines for celiac disease in 2014.
Nadhem ON; Azeez G; Smalligan RD; Urban S
Postgrad Med; 2015 Apr; 127(3):259-65. PubMed ID: 25702766
[TBL] [Abstract][Full Text] [Related]
18. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease: diagnosis and management.
Pelkowski TD; Viera AJ
Am Fam Physician; 2014 Jan; 89(2):99-105. PubMed ID: 24444577
[TBL] [Abstract][Full Text] [Related]
20. [Celiac disease--a diagnostic and therapeutic challenge].
Kaukinen K; Collin P; Mäki M
Duodecim; 2010; 126(3):245-54. PubMed ID: 20402035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
